Disorders of Short Stature
Pediatric Growth Hormone Deficiency
Adult Growth Hormone Deficiency
rGH Pharmaceutical Manufacturers
Links to Organizations & Information
Clinical Trials and Studies
Medical Insurance Issues
Pediatric Discussion Forum
Adult Discussion Forum
Annual Research Grant Program
HGF Gift Giving Program
Short and OK
Ready for School
Patterns of Growth
rowth Hormone Deficiency
Join the Human Growt Foundation
PAY ON-LINE WITH PAYPAL
A PayPal account is not required.
All major credit cards are accepted.
Simply click the "DONATE" button below.
Merchants donate to HGF at no cost to you. Your donations are tax deductible! Click on the iGIVE.COM icon below, sign up, install the tool bar, and you are good to go! Tell your family and friends!
(Click on the Bears)
Please see our first product for sale in the new HGF Retail Store: A beautiful music extended play (EP) CD that children and families will love.
The following are links to websites that provide an introductions to clinical studies and trials: what they are, how they work, and the services they provide.
The following are links to websites that provide listings and search capability for clinical studies and trials.
AXDEV Group and The Endocrine Society invite you to participate in a needs assessment in the areas of pediatric growth and adult growth hormone disorders.
If you or someone in your family is directly affected by a growth or growth hormone disorder, this study is an opportunity for you, as a patient or caregiver, to share your experiences in receiving care and counseling from health care providers, and to have an impact on physicians’ continuing medical education. The goal is to obtain a more comprehensive understanding of the clinical challenges and educational needs of endocrinologists and of primary care pediatricians in screening, testing, diagnosing, treating, and managing growth and growth hormone disorders.
• Involves a 45-minute telephone interview about your experience of care
• Has been reviewed by an independent board to ensure that it respects
the confidentiality as well as the right and welfare of participants
• Provides a financial compensation of $50.00 for participants’ time and
For more details or to register to this study, please call AXDEV at 1-888-282-9338 (toll-free) (Confidentiality respected) or log on to: http://www.axdevsurveys.com/survey/370703/142d/
TWO TURNER SYNDROME STUDIES FOR INFANTS OR SOON-TO-BE BORN, AND For Infants (or those soon-to-be born) and Children with Turner Syndrome: Invitation to Participate in Research Studies of Early Brain Development
UNC is currently seeking participants for STUDY 2 of early brain development in Turner syndrome (TS). These studies have been expanded to include girls with any TS karyotype except for those who have a Y chromosome component.
STUDY 1. [CLOSED] The purpose of this research study is to learn about brain development in children with TS beginning at two weeks of age. We are interested in whether the size of certain brain structures can tell us something about a child’s development. Your child will have a magnetic resonance imaging (MRI) scan of the brain in the first month of life at the University of North Carolina at Chapel Hill. An MRI does not use X-rays or radiation. All children will be scanned while sleeping naturally. Your child will also receive a thorough assessment of their behavioral development and a complete physical examination. Children will be invited back for similar follow-up assessments at 6, 12 and 24 months of age. If you were unable to participate in the initial assessment at 2 weeks of life, you may still be eligible to participate.
STUDY 2. [OPEN] Most children with TS have early growth failure and are treated with growth hormone. The purpose of this research study is to learn what effect growth hormone (GH) has on early brain development in children with TS. Girls will enter the study at 12 months of age and undergo an MRI, behavioral and physical examinations (as in study #1). They will be randomized into two groups: one group will receive GH for the following year while the other group will not (the control group). At 24 months of age, the subjects will return to Chapel Hill for repeat testing. Girls who did not receive GH during the study, will be given GH free of charge for the following year.
There will be no cost to families for participating in either study. The MRI, developmental evaluations, physical examination and GH are free of charge. Air travel and hotel arrangements will be made by research staff. If you travel by car we will reimburse you for the mileage.
To learn more about this study, please call: Dr. Marsha Davenport at 919-966-4435 x 232 or visit our website at http:www.turnersyndromestudygroup.org. (Posted April 18, 2011; updated April 24, 2013)
TURNER SYNDROME STUDY (FOR 16 TO 24 YEAR-OLD WOMEN WITH TURNER SYNDROME: EARLY BRAIN DEVELOPMENT
This is a research study involving the transitioning experiences of 16 to 24 year-old women with Turner Syndrome. This study will provide information on what these young women experience as they manage issues that are important to them during this time of change in their lives.
Any woman with Turner syndrome who are 16 to 24 years old is eligibile to participate in this study provided that she can read and write the English language, understands the purpose of the study, and is willing to answer questions in a personal interview by an experienced endocrine endocrine nurse; and to share her personal story.
For more information, please contact the principal investigator, Kelly Behm, RN, Rush University, College of Nursing: (407)455-4986 or (firstname.lastname@example.org. (Posted January 10, 2011)
ESTROGEN DOSING IN TURNER SYNDROME: PHARMACOLOGY AND METABOLISM
This is a research study on the choices of type, dose, and route of delivery of estrogen that are suitable in feminizing and sustaining estrogen concentrations in young women with Turner syndrome (TS). The focus of the study is TS girls who have already achieved their maximal growth, and who are not on growth hormone replacement therapy.
mours.org) or Judith Ross, MD, Co-Investigator (email@example.com).
FOR SOON-TO-BE-BORN AND NEWBORNS WITH TURNER SYNDROME: INVITATION TO PARTICIPATE IN A RESEARCH STUDY OF EARLY BRAIN DEVELOPMENT
The purpose of this research study is to learn about early brain development in children with Turner Syndrome. We are interested in whether the size of certain brain structures can tell us something about a child’s development. Your child will have a magnetic resonance imaging (MRI) scan of the brain in the first month of life at the University of North Carolina at Chapel Hill. An MRI does not use X-rays or radiation.
There will be no cost to families for participating. The MRI is free of charge and air travel and hotel arrangements will be made by research staff. If you travel by car we will reimburse you for the mileage. Clinical evaluations can be scheduled on the same day with Dr. Marsha Davenport, a pediatric endocrinologist who is an expert in Turner syndrome, and Dr. Maria Escolar, a pediatrician who is an expert in neurodevelopment. To learn more about this study, please call:
Dr. Marsha Davenport at 919-966-4435 x 232 or
Dr. Maria Escolar at 919-966-4465
(Posted June 13, 2008)
TREATMENT OF IDIOPATHIC SHORT STATURE IN CHILDREN (STUDY):
PREVALENCE AN METABOLIC CONSEQUENCES OF GROWTH HORMONE DEFICIENCY IN ABDOMINAL OBESITY OVERWEIGHT? (LARGE WAIST (STUDY):Makimura, M.D., Ph.D.
(617) 726-8277. (Posted January 12, 2008.)
Precocious Pubety Marketing Study on the Current Status and Future Direction of the Precocious Market Marketplace: GfK V2, a marketing firm on behalf of a pharmaceutical manufacturer, is conducting a marketing study, using telephone interviews with parents of young patients with precocious puberty, to learn of their (1) experiences and day-to-day issues in the treatment of precocious puberty for their children; (2) views on how the current treatment for precocious puberty could be improved; and (3) views regarding new materials for parents of children with precocious puberty.
To schedule a convenient day and time for the telephone interview, please call 1-888-798-1889. You will be asked several questions to confirm that you qualify to participate in the interview, which will take approximately 45 minutes.
For your participation we are offering an honorarium of $100. The interviews are confidential; and comply with the Code of Standards and Ethics for Survey Research and with HIPAA.
Gene, Brain and Behavior in Turner Syndrome (Children): Turner Girls ages 3-12 years with non-mosaic TS, Nationwide: Genetic factors, brain development and cognitive-behavioral functioning in TS. Participation will involve a 3-4 day evaluation that could include cognitive behavioral evaluation, brain imaging using magnetic resonance imaging (MRI, a non-invasive imaging procedure that does not use x-ray or radiation), and a simple blood test. Benefits of participating include free cognitive and behavioral assessment with a research report of assessment results that can be useful for educational planning, access to ongoing updates about the outcomes of the study, and a $150 honorarium. Travel arrangements will be made by research staff so that there will be no cost to families for participating.
Turner Girls ages 7-12 years: Stanford University Area Only: Cognitive intervention program on improving executive and visual-spatial skills. Participation will involve four weeks of cognitive intervention therapy including a home computer based practice one hour per day, five days per week, one parent training session to ensure effective at-home practice, weekly intervention training sessions under the direction of a licensed clinical neuropsychologist, and post-intervention cognitive evaluation and MRI scan. Benefits of participation include research-based intervention for executive function deficits and a report detailing the results of the neuropsychological evaluation that can be helpful in educational planning.
The studies are being conducted by The Center for Interdisciplinary Brain Sciences Research (CIBSR), Stanford University, http://spnl.stanford.edu. For more information, or to enroll in the study, send email to firstname.lastname@example.org; or, call toll free: 1-888-411-2672.
IGF-I Study: Recombinant Growth Factor-I (IGF-I) Study: Growth Failure in Noonan Syndrome (Children). The rationale for researching this particular therapy (recombinant human insulin-like growth factor-I (IGF-I), and one of its binding proteins, insulin growth factor binding protein-3 (IGFBP-3), is that it may bypass a problem that could adversely affect the response to growth hormone in children with Noonan syndrome. The study is being carried out to see if giving the study drug for one year will improve the growth of the study population. Children may qualify for the study if they:
- have been diagnosed with Noonan syndrome or are suspected of having Noonan syndrome
- are below a certain height
- are at least 2 years old and not yet in puberty
- are not currently being treated with recombinant human growth hormone
If you are interested in finding out more about our clinical study please visit www.insmed.com,or share this information with your physician.
Growth Hormone Market Research Study (Children) Market Research Survey. A medical market research survey by a UK based market research company is conducting a telephone survey amongst parents of children taking growth hormones. Questions will relate to satisfaction with growth hormones and unmet needs in this therapy area. The interview will be conducted over the phone and will last approx 30 minutes. Each participant will be offered $40 (cheque) to thank them for help and time. A donation will also be made to the Human Growth Foundation.
The survey is conducted for research purposes only -- no sales are involved and no medication will be used. All interviews are treated in complete confidentiality. The survey needs to be completed by the 10th May. If you would like more information or would like to register to take part, please email us, including the following information:
Please email these 2 addresses ASAP (before May the 10th, 2006): REF5085@fieldworkinternational.com AND email@example.com. You may also call the following toll-free number and leave a message 1-866 382 3839 - Sophie Wintrich, Jon or Lucy (Project T6334 parents)
- please quote Project T6334-parents
- age(s) of your child/children taking growth hormones
- your time zone (we are calling from the UK)
- the growth hormone you are using currently (and in the past, if you have changed)
IGF-I Study: Recombinant Growth Factor-I (IGF-I) Study: Growth Failure Due to Primary IGF-I Deficiency (Primary IGFD) (Children): Research study of children with primary insulin-like growth factor-I deficiency (Primary IGFD). Primary IGFD is characterized by adequate growth hormone, low IGF-I, low growth velocity, and short stature. In primary IGFD, a cellular or genetic defect prevents the body from utilizing growth hormone to produce IGF-I. IGF-I is a principal hormone necessary for statural growth and development. Without IGF-I, the children's bones, cartilage, organs do not grow normally. Clinical trials are currently being conducted throughout the United States to determine the safety and efficacy of recombinant human IGF-1 in children with growth failure due to Primary IGFD.
If your child produces adequate growth hormone, has low IGF-I, but is not growing well, he or she may have Primary IGFD. If you are interested in participating in this study, please call Tercica's Clinical Trials toll-free number at 866-279-9886 to receive information about physicians participating in your area. Children who qualify will receive study medication, medical evaluations and all other study-related procedures at no cost.